Content
Breadcrumbs
BTEC to host NC State/Seqirus technical symposium Dec. 7
BTEC will host the third NC State/Seqirus Technical Symposium from 1:00–5:00 p.m. Monday, Dec. 7, 2015, in room 135. Seqirus (Sek-eer-us) is the new name for Novartis influenza vaccines under the global biotherapeutics leader CSL.
The program is as follows:
| Title | Presenter |
|---|---|
Basic discoveries about formation of T cell memory to influenza explain weaknesses in current vaccine approaches and suggest potential improvements |
Susan Swain, Ph.D., Professor of Immunology, University of Massachusetts Medical School |
A WHO-BARDA-BTEC partnership for hands-on training in influenza vaccine manufacture |
Jennifer Pancorbo, Ph.D., Assistant Director, Bioprocess Services, BTEC |
Acetalated dextran: a spoonful of sugar helps the medicine (and vaccines) go down |
Kristy Ainslie, Ph.D., Division of Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina – Chapel Hill |
History of emulsion based adjuvants and their use in influenza vaccination |
Manmohan Singh, Head of Global Technology Development, Seqirus |
Interested individuals are invited to attend. No pre-registration is necessary.